3 drug(s) with this reaction
86 total reports
Oral Mucosal Exfoliation has been reported as an adverse reaction across 3 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 86 adverse event reports mention oral mucosal exfoliation in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with oral mucosal exfoliation, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have oral mucosal exfoliation listed in their FDA adverse event reports, sorted by report count:
In addition to oral mucosal exfoliation, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
3 drug(s) manufactured by Haleon Us Holdings Llc have oral mucosal exfoliation listed in their FDA adverse event reports: STANNOUS FLUORIDE, POTASSIUM NITRATE AND SODIUM FLUORIDE, POTASSIUM NITRATE, SODIUM FLUORIDE.
There are a combined 86 reports of oral mucosal exfoliation across 3 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.